Showing 1 - 20 results of 73 for search 'D V Nebieridze', query time: 0.04s Refine Results
  1. 1
    COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

    COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS» by D. V. Nebieridze

    Published 2015-12-01
    Get full text
    Article
  2. 2
    COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

    COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS» by D. V. Nebieridze

    Published 2015-12-01
    Get full text
    Article
  3. 3
    Aktual'nye voprosy lecheniyaarterial'noy gipertenzii:fokus na kombinirovannuyu terapiyu

    Aktual'nye voprosy lecheniyaarterial'noy gipertenzii:fokus na kombinirovannuyu terapiyu by D V Nebieridze

    Published 2011-09-01
    Get full text
    Article
  4. 4
    Kombinirovannaya terapiya arterial'noy gipertenzii: novaya nefiksirovannaya kombinatsiya

    Kombinirovannaya terapiya arterial'noy gipertenzii: novaya nefiksirovannaya kombinatsiya by D V Nebieridze

    Published 2007-03-01
    Get full text
    Article
  5. 5
    Hyperuricemia a New Cardiovascular Risk Factor

    Hyperuricemia a New Cardiovascular Risk Factor by D. V. Nebieridze

    Published 2020-03-01
    Get full text
    Article
  6. 6
    Topical issues of beta-blockers use in various clinical situations

    Topical issues of beta-blockers use in various clinical situations by D. V. Nebieridze

    Published 2018-07-01
    Get full text
    Article
  7. 7
    Topical questions of beta-blockers application in clinical practice

    Topical questions of beta-blockers application in clinical practice by D V Nebieridze

    Published 2014-12-01
    Get full text
    Article
  8. 8
    COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

    COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION by D. V. Nebieridze

    Published 2016-01-01
    Get full text
    Article
  9. 9
    SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

    SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS by D. V. Nebieridze

    Published 2002-02-01
    Get full text
    Article
  10. 10
    Main questions of β-blockers application in clinical practice: do they all the same?

    Main questions of β-blockers application in clinical practice: do they all the same? by D V Nebieridze

    Published 2016-09-01
    Get full text
    Article
  11. 11
    CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

    CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS by D. V. Nebieridze

    Published 2015-12-01
    Get full text
    Article
  12. 12
    Hyperuricemia a New Cardiovascular Risk Factor

    Hyperuricemia a New Cardiovascular Risk Factor by D. V. Nebieridze

    Published 2020-03-01
    Get full text
    Article
  13. 13
    CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

    CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS by D. V. Nebieridze

    Published 2015-12-01
    Get full text
    Article
  14. 14
    Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

    Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II by A. S. Safaryan, D. V. Nebieridze

    Published 2021-10-01
    Get full text
    Article
  15. 15
    ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

    ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? by D. V. Nebieridze, A. S. Safarian

    Published 2016-01-01
    Get full text
    Article
  16. 16
    Imidazoline receptor agonists: more than blood pressure reduction?

    Imidazoline receptor agonists: more than blood pressure reduction? by D. V. Nebieridze, S. V. Nedogoda

    Published 2006-04-01
    Get full text
    Article
  17. 17
    Place of imidazoline receptor agonists in the treatment of hypertension

    Place of imidazoline receptor agonists in the treatment of hypertension by D. V. Nebieridze, A. S. Safaryan

    Published 2022-01-01
    Get full text
    Article
  18. 18
    IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

    IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? by D. V. Nebieridze, T. V. Kamyshova

    Published 2015-12-01
    Get full text
    Article
  19. 19
    IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

    IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? by D. V. Nebieridze, T. V. Kamyshova

    Published 2015-12-01
    Get full text
    Article
  20. 20
    High-risk patients: modern treatment strategy

    High-risk patients: modern treatment strategy by D. V. Nebieridze, A. Meliya

    Published 2010-12-01
    Get full text
    Article

Search Tools: